Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02070315 · ClinicalTrials.gov registry record
Quantitative Evaluation of the Progression of Liver Disease, Using ShearWaveTM
A clinical trial of Heart Failure and Liver Disease, sponsored by Baylor Research Institute.
- Completed
- Registry status
- 1,247
- Enrollment target
- 1
- Study location
NCT02070315 is a study of Heart Failure and Liver Disease that has completed, run by Baylor Research Institute. The registered enrollment target is 1,247 participants, below the 2,046-participant average among 397 other Heart Failure trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02070315, a study of Heart Failure and Liver Disease, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- 1,247 participants
- Enrollment target
- 1
- Study location
Study Summary
Liver biopsy for the assessment of fibrosis has multiple limitations. Liver ShearWaveTM Elastography may provide a non-invasive, fast, and reproducible alternative for the quantitative assessment of liver fibrosis.
Conditions Studied
Study Locations (1)
Texas
- Baylor University Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,247 participants |
| Start Date | 2012-02 |
| Est. Completion | 2022-04-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02070315
The ClinicalTrials.gov registry entry for NCT02070315 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,247 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,046-participant average among 397 other Heart Failure trials with a reported enrollment target (39% lower). The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT02070315 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02070315 about?
NCT02070315 is a clinical study titled "Quantitative Evaluation of the Progression of Liver Disease, Using ShearWaveTM". Liver biopsy for the assessment of fibrosis has multiple limitations. Liver ShearWaveTM Elastography may provide a non-invasive, fast, and reproducible alternative for the quantitative assessment of liver fibrosis.
What is the current status of trial NCT02070315?
This trial is currently completed. The enrollment target is 1,247 participants. The study started on 2012-02. Estimated completion is 2022-04-28.
What conditions does trial NCT02070315 study?
This clinical trial studies the following conditions: Heart Failure, Liver Disease.
Who is sponsoring clinical trial NCT02070315?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02070315 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.